Usefulness of Serum Triiodothyronine (T3) To Predict Outcomes in Patients Hospitalized With Acute Heart Failure

Abstract Thyroid hormone plays an important role in cardiac function. Low levels of serum triiodothyronine (T3 ) due to nonthyroidal illness syndrome may have adverse effects in heart failure (HF). This study was designed to assess the ability of T3 to predict in–hospital outcomes in patients with acute HF. In total, 137 patients without thyroid disease or treatment with drugs which affect TH levels, who were hospitalized with acute HF were prospectively enrolled and studied. TH levels were tested upon hospital admission, and outcomes were compared between patients with low (< 2.3 pg/mL) and normal (≥ 2.3 pg/mL) free T3 levels as well as between those with low (< 0.6 ng/mL) and normal (≥ 0.6 ng/mL) total T3 levels. Low free T3 correlated with an increased length of stay in the hospital (median 11 days vs. 7 days, p < 0.001), and higher rates of intensive care unit (ICU) admission (31.8% vs. 16.9%, p = 0.047), with a trend toward increased need for invasive mechanical ventilation (9.0% vs. 1.4%, p = 0.056). Low total T3 correlated with an increased length of stay in the hospital (median 11 days vs. 7 days, p < 0.001) and increased need for invasive mechanical ventilation (9.8% vs. 1.3%, p = 0.045). In conclusion, low T3 predicts worse hospital outcomes in patients with acute HF and can be useful in the risk stratification of these patients.